Ortec International Inc. (ORTN.OB) Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
1/10/2008 8:34:46 AM
More...
|
Ortec International Inc. (ORTN.OB) Announces Revised Date and Time for Presentation at New York Society of Security Analysts Conference
12/11/2007 1:58:46 PM
More...
|
Ortec International Inc. (ORTN.OB) Selected to Present among Leading Life Science Companies at New York Society of Security Analysts Conference
12/5/2007 11:52:21 AM
More...
|
Ortec International Inc. (ORTN.OB) Files PMA for OrCel(R) for VLU Indication
10/23/2007 8:24:32 AM
More...
|
Ortec International Inc. (ORTN.OB) Announces New CEO
7/11/2007 8:36:50 AM
More...
|
Ortec International Inc. (ORTN.OB) Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers
2/26/2007 10:17:44 AM
More...
|
Ortec International Inc. (ORTN.OB) And Paul Capital Healthcare To Restructure Existing Financing Agreement
11/30/2006 10:53:07 AM
More...
|
FDA Issues Approvable Letter To Ortec International Inc. (ORTN.OB) For Use Of Cryopreserved OrCel(R) In Epidermolysis Bullosa Patients' Hand Reconstructions And Donor Sites
9/29/2006 1:02:12 PM
More...
|
Ortec International Inc. (ORTN.OB) Obtains Second U.S. Patent Allowance On Haptide Cell Attachment Technology
9/20/2006 2:25:43 PM
More...
|
Ortec International Inc. (ORTN.OB) Announces Positive Results In Confirmatory Venous Leg Ulcer Trial
9/12/2006 11:44:43 AM
More...
|
|